期刊
CURRENT GENOMICS
卷 10, 期 3, 页码 154-168出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920209788185252
关键词
Aging; Alzheimer disease; biomarker; microRNA; mild cognitive impairment; neurodegeneration; genomics
资金
- Sir Mortimer B. Davis-Jewish General Hospital
- Kentucky Bucks-for-Brains
- Gheens Foundation Endowment funds
Understanding complex diseases such as sporadic Alzheimer disease (AD) has been a major challenge. Unlike the familial forms of AD, the genetic and environmental risks factors identified for sporadic AD are extensive. MicroRNAs are one of the major noncoding RNAs that function as negative regulators to silence or suppress gene expression via translational inhibition or message degradation. Their discovery has evoked great excitement in biomedical research for their promise as potential disease biomarkers and therapeutic targets. Key microRNAs have been identified as essential for a variety of cellular events including cell lineage determination, proliferation, apoptosis, DNA repair, and cytoskeletal organization; most, if not all, acting to fine-tune gene expression at the post-transcriptional level in a host of cellular signaling networks. Dysfunctional microRNA-mediated regulation has been implicated in the pathogenesis of many disease states. Here, the current understanding of the role of miRNAs in the central nervous system is reviewed with emphasis on their impact on the etiopathogenesis of sporadic AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据